Join Bass, Berry & Sims and leading industry dealmakers for a series of lively panel discussions focused on the nuts and bolts of executing a buy or sell-side deal in a post-pandemic environment. Each discussion in this series will focus on industry-specific guidance, including manufacturing, food & beverage/retail, government contracts, and healthcare, among others.

With social distancing and travel limitations, regulatory changes, COVID-19-specific diligence, valuations, and financing considerations top of mind, panelists will share their experiences and perspectives on what deal professionals should consider in a new and evolving market.


  • Scott Alford, Houlihan Lokey – Managing Director
  • Michael Holley, Bass, Berry & Sims – Corporate & Securities Attorney
  • Chris Lin, LFM Capital – Managing Director
  • Frank Pellegrino, Bass, Berry & Sims – Corporate & Securities Attorney
  • Scott Purtill, Plante Moran – Partner

Discussion topics

  • Bridging Valuation Gaps – Earn Outs, Holdbacks, Escrows.
  • Financing Issues – Seller Financing, Access to Debt Capital, Equity Only Funded Deals.
  • Transaction Structures – Minority or Majority Investments, Distressed Sales.
  • Material Adverse Effect Conditions.
  • COVID-19 Related Diligence.
  • CARES Act/PPP Funding.
  • Reps & Warranties Exclusions.

Who Should Attend?

  • C-level executives, consultants, and principals in the manufacturing industry.
  • In-house legal counsel.
  • Private equity fund managers and portfolio company executives.
  • Senior and mezzanine lenders.
  • Investment bankers and M&A advisors.


Submit your questions for presenters upon registration or email questions to Lauren Parkhurst.